Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT).
Georgopoulos A, Bloomfield H, Collins D, Brousseau ME, Ordovas JM, O'Connor JJ, Robins SJ, Schaefer EJ. Georgopoulos A, et al. Atherosclerosis. 2007 Sep;194(1):169-74. doi: 10.1016/j.atherosclerosis.2006.07.022. Epub 2006 Aug 30. Atherosclerosis. 2007. PMID: 16945373 Clinical Trial.
Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial.
Brousseau ME, Goldkamp AL, Collins D, Demissie S, Connolly AC, Cupples LA, Ordovas JM, Bloomfield HE, Robins SJ, Schaefer EJ. Brousseau ME, et al. Among authors: bloomfield he. J Lipid Res. 2004 Oct;45(10):1885-91. doi: 10.1194/jlr.M400152-JLR200. Epub 2004 Aug 1. J Lipid Res. 2004. PMID: 15292370 Free article. Clinical Trial.
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.
Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ. Asztalos BF, et al. Among authors: bloomfield he. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2185-91. doi: 10.1161/01.ATV.0000183727.90611.4f. Epub 2005 Aug 25. Arterioscler Thromb Vasc Biol. 2005. PMID: 16123324
The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).
Tai ES, Collins D, Robins SJ, O'Connor JJ Jr, Bloomfield HE, Ordovas JM, Schaefer EJ, Brousseau ME. Tai ES, et al. Among authors: bloomfield he. Atherosclerosis. 2006 Jul;187(1):153-60. doi: 10.1016/j.atherosclerosis.2005.08.034. Epub 2005 Oct 10. Atherosclerosis. 2006. PMID: 16221474 Clinical Trial.
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ. Otvos JD, et al. Among authors: bloomfield he. Circulation. 2006 Mar 28;113(12):1556-63. doi: 10.1161/CIRCULATIONAHA.105.565135. Epub 2006 Mar 13. Circulation. 2006. PMID: 16534013 Clinical Trial.
58 results